The European Union expects to receive more than 1 billion doses of COVID-19 by the end of September from four pharmaceutical companies, according to a document presented to European leaders today.
The document, accessed by Reuters and prepared by the European Commission, shows that the EU believes there will be enough vaccines to immunize the entire population.
More specifically, the EU expects to receive 413 million doses in the second quarter of this year and another 529 million in July-September. The bloc received 106 million vaccines in the first quarter.
Estimates take into account only vaccines from four pharmaceutical companies: Pfizer-BionTech, Johnson & Johnson, AstraZeneca and Moderna.
They exclude doses from German biotechnology company CureVac and French pharmaceutical company Sanofi, which have signed contracts with the EU for hundreds of millions of doses but are finding it difficult to develop their own vaccines and secure the approval of European regulators.